Kakao Healthcare and Skylabs Sign Agreement for Cart BP Supply and Digital Healthcare Service Collaboration

Supply of Ring-Type Continuous Blood Pressure Monitor "Cart BP"

Kakao Healthcare and the global healthcare company Skylabs announced on the 29th that they have signed a definitive agreement for the supply of the ring-type continuous blood pressure monitor "Cart BP" and cooperation in digital healthcare services. The goal is to provide innovative digital healthcare services by combining Kakao Healthcare's mobile and AI technology with Skylabs' expertise in biosignal measurement technology.

Kakao Healthcare signed a contract on the 28th at its headquarters in Seongnam, Gyeonggi Province, with Skylabs for the supply of Cart Bifi and cooperation in digital healthcare services. From the left in the photo, Byeonghwan Lee, CEO of Skylabs, and Hee Hwang, CEO of Kakao Healthcare, are taking a commemorative photo. Photo by Kakao Healthcare

The two companies signed a memorandum of understanding in May 2022 to collaborate on mobile-based chronic disease management. With this definitive agreement, they have pledged comprehensive cooperation, including the supply and distribution of Skylabs' ring-type continuous blood pressure monitor "Cart BP" and the launch of digital healthcare services utilizing continuous blood pressure data.

Kakao Healthcare will introduce a new blood pressure management service to its AI-based mobile health management solution "PASTA" app in December. By linking with Cart BP, the app will allow users to monitor real-time blood pressure changes based on daily lifestyle habits such as diet and exercise. In particular, it will provide guidance for blood pressure management, helping patients with hypertension improve their lifestyle habits independently.

The PASTA app is expected to evolve into an all-in-one solution for chronic disease management by expanding its service scope from blood glucose, obesity, and sleep to include blood pressure. Kakao Healthcare plans to continuously enhance its digital healthcare services so that patients with chronic diseases can manage their health more easily and systematically.

The two companies will also actively work to promote Cart BP. Cart BP received medical device approval from the Ministry of Food and Drug Safety and began official sales to general consumers in September. They are currently working to enter institutional markets, including insurance coverage, in major European countries. The companies plan to introduce their products and services to a variety of customers, including individual patients, businesses, and pharmacies, primarily through online channels. In addition, they intend to develop products and services that link Cart BP with insurance, thereby increasing accessibility for patients with hypertension.

Byeonghwan Lee, CEO of Skylabs, said, "As global demand for personalized health management services rises, we expect that collaboration with Kakao Healthcare will enable us to provide a broader range of digital healthcare services to more users. Based on the resources of both companies, we will develop excellent products and services to support the daily health management of patients with chronic diseases."

Hee Hwang, CEO of Kakao Healthcare, stated, "Hypertension is a representative chronic disease that requires patients to improve their lifestyle habits outside the hospital, making digital healthcare closely connected to daily life an essential area. By linking the wearable medical device 'Cart BP' with the digital healthcare solution 'PASTA,' we will help patients stay motivated and gradually improve their lifestyle habits in their everyday lives."

This content was produced with the assistance of AI translation services.